The ASPECT Study - Asian Paclitaxel-Eluting Stent Clinical Trial

Inclusion Criteria: * Patient must be eligible to undergo planned treatment of a single de novo lesion in a native coronary artery. * Patient must be an acceptable candidate for coronary artery bypass surgery. * Patient must have given signed informed consent. * Patient agrees to return at one month for an office visit to assess cardiovascular status and at 4-6 months for an office visit to assess cardiovascular status and for a diagnostic angiogram. Exclusion Criteria: * Patient is less than 18 years old. * Patient has history of bleeding diathesis or coagulopathy or will refuse blood transfusions. * The patient is simultaneously participating in another investigative interventional cardiovascular device or drug study. * Patient has known hypersensitivity or contraindication to aspirin, Clopidogrel, or stainless steel, or a sensitivity to contrast dye that. * Patient is pregnant. * Patient has other medical condition that may cause the patient to be non-compliant with the protocol, confound the results or is associated with limited life expectancy.